Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1999
10/19/1999US5968505 Compounds rich in glucosinolates such as glucoraphanin as anticarcinogenic agents, screening
10/19/1999US5968482 Radiation resistant filters for light protection of cosmetics and drugs
10/19/1999CA2154913C Magnetically responsive composition for carrying biologically active substances and methods of production and use
10/19/1999CA1340792C Pyrido[2,3-d]pyrimidine deratives
10/17/1999CA2269262A1 Substituted tricyclics
10/16/1999CA2269049A1 N-acyl and n-aroyl aralkyl amides
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051741A2 Lyst protein complexes and lyst interacting proteins
10/14/1999WO1999051732A1 Secreted proteins and polynucleotides encoding them
10/14/1999WO1999051727A2 Human nucleic acid sequences of normal ovary tissue
10/14/1999WO1999051643A1 Mutagenized il13-based chimeric molecules
10/14/1999WO1999051640A1 Human oxidized ldl receptor
10/14/1999WO1999051638A1 DUAL Avb3 AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS
10/14/1999WO1999051635A1 Transcription factors and their use
10/14/1999WO1999051628A1 Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer
10/14/1999WO1999051596A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051595A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051594A1 IMIDAZO[1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS
10/14/1999WO1999051562A1 Novel retinoids and use thereof
10/14/1999WO1999051284A2 Non-covalent bioconjugates useful for diagnosis and therapy
10/14/1999WO1999051278A1 Inorganic material for radioactive drug delivery
10/14/1999WO1999051270A1 A novel nitroreductase and therapeutic uses therefor
10/14/1999WO1999051268A1 Immunomodulatory compositions of mmtv antigens and methods of using same
10/14/1999WO1999051263A2 Methods and modified cells for the treatment of cancer
10/14/1999WO1999051259A2 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
10/14/1999WO1999051257A1 Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient
10/14/1999WO1999051248A1 New combined preparation for the treatment of neoplasic diseases or of infectious diseases
10/14/1999WO1999051246A1 Antitumor agents
10/14/1999WO1999051241A1 Calcilytic compounds and method of use
10/14/1999WO1999051238A1 Semi-synthetic ecteinascidins
10/14/1999WO1999051236A1 Methods for inhibiting mrp1
10/14/1999WO1999051234A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051233A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051232A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051231A1 Antagonists of gonadotropin releasing hormone
10/14/1999WO1999051228A1 Methods for inhibiting mrp1
10/14/1999WO1999051227A1 Methods for inhibiting mrp1
10/14/1999WO1999051224A1 Indolyl-3-glyoxylic acid derivatives with antitumoral activity
10/14/1999WO1999051217A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999WO1999051206A1 Cationic lipid formulation delivering nucleic acid to peritoneal tumors
10/14/1999WO1999051185A2 Human galactosyl transferases
10/14/1999WO1999044628A8 Conjugates useful in the treatment of prostate cancer
10/14/1999WO1999042579A3 Caf1-related protein
10/14/1999WO1999042089A3 Use of thiadiazolo[4,3-a]pyridine derivatives
10/14/1999WO1999040188A3 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations
10/14/1999WO1999039702A3 Method for regulating size and growth of vascularized normal tissue
10/14/1999WO1999037660A9 Meth1 and meth2 polynucleotides and polypeptides
10/14/1999WO1999036094A9 Composition and method for treating metastatic tumors or cancer induced by cells expressing sv40 tumor antigen
10/14/1999WO1999034824A3 Tumour vaccines for muc1-positive carcinomas
10/14/1999WO1999031225A3 Human phosphatases
10/14/1999WO1999010486A3 Mdm2-specific antisense oligonucleotides
10/14/1999DE19901732A1 Herbal composition for tumor therapy
10/14/1999DE19816116A1 Preparation of conditionally immortalized immortalization-helper cells, used to immortalize mammalian cells, e.g. for production of hybridomas
10/14/1999DE19815331A1 Transkriptionsfaktoren und deren Verwendung Transcription factors and their use
10/14/1999DE19814838A1 Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung Indolyl-3-glyoxylic acid derivatives having anti-tumor activity
10/14/1999CA2328181A1 Immunomodulatory compositions of mmtv antigens and methods of using same
10/14/1999CA2327706A1 Methods for inhibiting mrp1
10/14/1999CA2327617A1 Methods for inhibiting mrp1
10/14/1999CA2327452A1 Methods for inhibiting mrp1
10/14/1999CA2327188A1 Calcilytic compounds and method of use
10/14/1999CA2326978A1 Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer
10/14/1999CA2326977A1 Inorganic material for radioactive drug delivery
10/14/1999CA2326739A1 Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient
10/14/1999CA2326650A1 Azo and diaza dericatives and uses thereof in phototherapy
10/14/1999CA2326185A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326184A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326143A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326140A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326139A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2326130A1 Cationic lipid formulation delivering nucleic acid to peritoneal tumors
10/14/1999CA2325995A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2325562A1 Lyst protein complexes and lyst interacting proteins
10/14/1999CA2325342A1 Dual avb3 and metastasis-associated receptor ligands
10/14/1999CA2325341A1 Mutagenized il13-based chimeric molecules
10/14/1999CA2325339A1 Dadd, death activator death domain protein
10/14/1999CA2325050A1 A novel nitroreductase and therapeutic uses therefor
10/14/1999CA2325007A1 Human galactosyl transferases
10/14/1999CA2324984A1 Secreted proteins and polynucleotides encoding them
10/14/1999CA2324976A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999CA2324868A1 Human oxidized ldl receptor
10/13/1999EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999EP0948651A1 Recombinant n-smases and nucleic acids encoding same
10/13/1999EP0948623A2 Isolated mammalian monocyte cell genes; related reagents
10/13/1999EP0948622A1 Human mage-like protein
10/13/1999EP0948621A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
10/13/1999EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999EP0948611A1 Ve-cadherin promoter and its uses
10/13/1999EP0948545A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use
10/13/1999EP0948544A1 Monovalent antibody fragments
10/13/1999EP0948522A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
10/13/1999EP0948520A1 Tissue specific expression of retinoblastoma protein
10/13/1999EP0948518A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
10/13/1999EP0948517A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF
10/13/1999EP0948515A1 Human b-cell translocation genes-2 and 3
10/13/1999EP0948511A2 Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
10/13/1999EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use
10/13/1999EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999EP0948493A1 Indene inhibitors of cox-2
10/13/1999EP0948483A1 Farnesyl transferase inhibitors
1 ... 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 ... 2211